GLP-1 receptor agonists (GLP-1 RAs) have transformed the ma…

GLP-1 receptor agonists (GLP-1 RAs) have transformed the management of diabetes and obesity, delivering substantial metabolic benefits. But like any effective therapy, they are not without risks.

GLP-1 RAs are Powerful Therapies, but Safety Matters.

The message is not to avoid GLP-1 RAs, but to use them thoughtfully - Patient selection, baseline assessment, appropriate monitoring and early recognition of adverse events to maximize benefit while minimizing risk.

Source

Kim JA, Yoo HJ. Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning. Diabetes Metab J 2025;49:525-541. https://doi.org/10.4093/dmj.2025.0242